Molina Healthcare Inc (NYSE:MOH) Director Ronna Romney sold 250 shares of the business’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $58.00, for a total value of $14,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Ronna Romney also recently made the following trade(s):

  • On Friday, June 23rd, Ronna Romney sold 250 shares of Molina Healthcare stock. The stock was sold at an average price of $71.45, for a total value of $17,862.50.
  • On Wednesday, May 31st, Ronna Romney sold 250 shares of Molina Healthcare stock. The stock was sold at an average price of $63.26, for a total value of $15,815.00.

Molina Healthcare Inc (NYSE:MOH) traded up 0.90% during mid-day trading on Friday, hitting $58.05. The company had a trading volume of 1,541,262 shares. Molina Healthcare Inc has a 52 week low of $42.56 and a 52 week high of $72.79. The firm’s 50 day moving average is $67.67 and its 200 day moving average is $58.93. The company’s market capitalization is $3.32 billion.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Wednesday, August 2nd. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.86 by $0.87. Molina Healthcare had a negative net margin of 1.07% and a positive return on equity of 16.10%. The business had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.88 billion. During the same quarter last year, the firm earned $0.67 EPS. The firm’s quarterly revenue was up 14.7% on a year-over-year basis. On average, equities research analysts predict that Molina Healthcare Inc will post ($2.96) EPS for the current year.

TRADEMARK VIOLATION WARNING: “Molina Healthcare Inc (MOH) Director Sells $14,500.00 in Stock” was reported by American Banking News and is owned by of American Banking News. If you are viewing this article on another domain, it was illegally copied and republished in violation of international copyright legislation. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/08/11/molina-healthcare-inc-moh-director-sells-14500-00-in-stock.html.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. UBS Asset Management Americas Inc. raised its position in shares of Molina Healthcare by 91.8% in the fourth quarter. UBS Asset Management Americas Inc. now owns 62,757 shares of the company’s stock valued at $3,406,000 after buying an additional 30,033 shares during the period. Teachers Advisors LLC raised its position in shares of Molina Healthcare by 34.6% in the fourth quarter. Teachers Advisors LLC now owns 124,489 shares of the company’s stock valued at $6,755,000 after buying an additional 32,018 shares during the period. Capstone Asset Management Co. raised its position in shares of Molina Healthcare by 7.4% in the first quarter. Capstone Asset Management Co. now owns 7,556 shares of the company’s stock valued at $345,000 after buying an additional 520 shares during the period. Alpha Windward LLC raised its position in shares of Molina Healthcare by 11.2% in the first quarter. Alpha Windward LLC now owns 10,686 shares of the company’s stock valued at $487,000 after buying an additional 1,080 shares during the period. Finally, Louisiana State Employees Retirement System raised its position in shares of Molina Healthcare by 1.9% in the first quarter. Louisiana State Employees Retirement System now owns 10,700 shares of the company’s stock valued at $488,000 after buying an additional 200 shares during the period. Institutional investors and hedge funds own 93.42% of the company’s stock.

A number of brokerages have recently commented on MOH. Credit Suisse Group reaffirmed an “underperform” rating and set a $53.00 price target (up previously from $50.00) on shares of Molina Healthcare in a research report on Friday, July 14th. Bank of America Corporation upped their price target on Molina Healthcare from $59.00 to $60.00 and gave the company an “underperform” rating in a research report on Friday, July 14th. Jefferies Group LLC reaffirmed a “hold” rating and set a $72.00 price target on shares of Molina Healthcare in a research report on Friday, July 14th. Stifel Nicolaus reaffirmed a “sell” rating and set a $60.00 price target on shares of Molina Healthcare in a research report on Friday, July 14th. Finally, Zacks Investment Research cut Molina Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, July 17th. Five analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $62.18.

About Molina Healthcare

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Insider Buying and Selling by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.